Fluoxetine metabolism and pharmacological interactions: the role of cytochrome p450
about
Mirtazapine, and mirtazapine-like compounds as possible pharmacotherapy for substance abuse disorders: evidence from the bench and the bedsideThe role of metabolites in predicting drug-drug interactions: focus on irreversible cytochrome P450 inhibition.A consensus statement for safety monitoring guidelines of treatments for major depressive disorder.Process map proposal for the validation of genomic biomarkers.Pharmacokinetics and interactions of headache medications, part II: prophylactic treatments.Impact of combined treatment with rosuvastatin and antidepressants on liver and kidney function in ratsAmine oxidases and monooxygenases in the in vivo metabolism of xenobiotic amines in humans: has the involvement of amine oxidases been neglected?Review of evidence for genetic testing for CYP450 polymorphisms in management of patients with nonpsychotic depression with selective serotonin reuptake inhibitors.Physiological endpoints for potential SSRI interactions in fish.Olanzapine/fluoxetine combination for treatment-resistant depression: efficacy and clinical utility.Pharmacogenetics in reproductive and perinatal medicine.Review: Pharmacogenetic aspects of the effect of cytochrome P450 polymorphisms on serotonergic drug metabolism, response, interactions, and adverse effects.Drug safety evaluation of olanzapine/fluoxetine combination.Computational modeling of drug response with applications to neuroscience.Analytical methodologies for the stereoselective determination of fluoxetine: An overview.In vitro assessment of 39 CYP2C9 variants found in the Chinese population on the metabolism of the model substrate fluoxetine and a summary of their effects on other substrates.Hypoglycemia associated with fluoxetine treatment in a patient with type 1 diabetes.Quetiapine versus clomipramine in the augmentation of selective serotonin reuptake inhibitors for the treatment of obsessive-compulsive disorder: a randomized, open-label trial.Classics in Chemical Neuroscience: Fluoxetine (Prozac).Chirality of Modern Antidepressants: An Overview.Characterizing the effect of cytochrome P450 (CYP) 2C8, CYP2C9, and CYP2D6 genetic polymorphisms on stereoselective N-demethylation of fluoxetine.
P2860
Q24622161-90D80F25-7B05-4978-9C67-90C8DE1184BDQ33967634-96C82A23-D5E4-46C5-9ED5-9780BA2C87C8Q35311467-1BDDF949-1FBF-44AC-A138-5EBCDAF14A92Q36555934-9D42866E-AAEE-45A6-9681-80FCB69B00DAQ36662893-9B03C047-6B63-47ED-A8B7-38279B52AC24Q36741741-EC385929-5D61-4990-B2A3-2BEA8710E6E0Q36941961-7BF4CEC7-5B55-458C-9176-61AE0BB04BC3Q37037060-1C93C53D-15CF-43B6-8EF2-056E30887C75Q37103805-FE5157A4-F103-4E21-BD90-B4BBE154147DQ37256691-DC26A0E7-C557-40EE-8610-47C19CBC0274Q37657531-34F77A49-6EAE-422D-9359-CF2C616844B3Q37807282-D3853F1A-7B15-4C59-83AE-6C6086530337Q38223945-A18EF73B-38B8-4E7C-AC55-F705BD630516Q38367112-20EEEE08-A29B-4B17-AF46-6448B5B0EFFEQ39410693-A7D3A971-82B5-430C-9279-22C4FD2A3A43Q41058254-B0CAC726-CE78-4E45-A843-D7A8705E9F81Q42856885-271057C5-DD58-4727-BE16-40B9FC1B133CQ46150867-A9577C55-B86D-4EA0-ACFA-F310557BBA06Q47110194-FD43ADAF-B3FC-4A48-A59D-A809CED03C56Q49299197-BE93603C-3F75-4246-A624-B32D6DBC8FD8Q52765416-7BFFB623-BCFC-489C-B482-D9B2F25FFA6C
P2860
Fluoxetine metabolism and pharmacological interactions: the role of cytochrome p450
description
2006 nî lūn-bûn
@nan
2006 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Fluoxetine metabolism and pharmacological interactions: the role of cytochrome p450
@ast
Fluoxetine metabolism and pharmacological interactions: the role of cytochrome p450
@en
Fluoxetine metabolism and pharmacological interactions: the role of cytochrome p450
@nl
type
label
Fluoxetine metabolism and pharmacological interactions: the role of cytochrome p450
@ast
Fluoxetine metabolism and pharmacological interactions: the role of cytochrome p450
@en
Fluoxetine metabolism and pharmacological interactions: the role of cytochrome p450
@nl
prefLabel
Fluoxetine metabolism and pharmacological interactions: the role of cytochrome p450
@ast
Fluoxetine metabolism and pharmacological interactions: the role of cytochrome p450
@en
Fluoxetine metabolism and pharmacological interactions: the role of cytochrome p450
@nl
P1476
Fluoxetine metabolism and pharmacological interactions: the role of cytochrome p450
@en
P2093
G Cantelli Forti
P304
P356
10.2174/138920006775541561
P407
P577
2006-02-01T00:00:00Z